Ravi Kurukulasuriya
Metabolic Disease Research
Global Pharmaceutical Research and Development
Abbott Laboratories
100 Abbott Park Road
USA
Name/email consistency: high
- Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors. Kurukulasuriya, R., Rohde, J.J., Szczepankiewicz, B.G., Basha, F., Lai, C., Jae, H.S., Winn, M., Stewart, K.D., Longenecker, K.L., Lubben, T.W., Ballaron, S.J., Sham, H.L., von Geldern, T.W. Bioorg. Med. Chem. Lett. (2006)
- Biaryl amide glucagon receptor antagonists. Kurukulasuriya, R., Sorensen, B.K., Link, J.T., Patel, J.R., Jae, H.S., Winn, M.X., Rohde, J.R., Grihalde, N.D., Lin, C.W., Ogiela, C.A., Adler, A.L., Collins, C.A. Bioorg. Med. Chem. Lett. (2004)